Revealed Preferences Analysis and US Preventative Services Task Force Breast Cancer Screening Guidelines

Size: px
Start display at page:

Download "Revealed Preferences Analysis and US Preventative Services Task Force Breast Cancer Screening Guidelines"

Transcription

1 Revealed Preferences Analysis and US Preventative Services Task Force Breast Cancer Guidelines No Financial Disclosures Contact: Anand Narayan, MD/PhD Elena Elkin, PhD Elizabeth Morris, MD

2 Revealed preference methods have been used in economics to ascertain consumer preferences by quantitatively analyzing consumer choices.

3 Implicit behind breast cancer screening guidelines are the preferences of guideline makers for acceptable trade offs between the benefits and harms of screening mammography, however these preferences are often not explicitly stated in the development of these guidelines.

4 Purpose The purpose of our study was to utilize revealed preference methods to ascertain implicit preferences and thresholds at which screening mammography is recommended.

5 USPSTF Guidelines Recommend Biennial in Women Between Implicit Quantitative Threshold in Recommending Above 50 but not below 50

6 Methods Data Sources Benefits of Mammography Breast Cancer Specific Mortality Reductions From US Preventative Services Task Force Harms of Mammography Number of False Positive Examinations From Breast Cancer Surveillance Consortium

7 Statistical Methods Ratios of harms (false ) to benefits (number of deaths prevented) were calculated using annual and biennial screening strategies above and below 50 years old. Sensitivity analyses were performed to determine the extent to which altering potential harms of screening mammography in women under age 50 would make breast cancer screening acceptable using thresholds using revealed preference thresholds

8 Results: Quantitative Harms of Mammography Cumulative False Positive Proportion over 10 Years Age Group Annual Biennial % 41.6% % 42.0% From: for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med. 2016;164(4): doi: /m Date of download: 3/14/2017 Copyright American College of Physicians. All rights reserved.

9 Quantitative Benefits of Breast Cancer Over 10 Years Age years Age years 3 breast cancer deaths avoided per 10,000 women screened 8 breast cancer deaths avoided per 10,000 women screened From: for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med. 2016;164(4): doi: /m Date of download: 3/14/2017 Copyright American College of Physicians. All rights reserved.

10 Quantitative Comparison of Harms vs Benefits of False Positive Examinations Required to Prevent 1 Death Age Group Annual 2043 false 766 false Biennial 1400 false 525 false

11 False Positive Examinations Required to Prevent 1 Death Age Group Annual 2043 false Biennial 1400 false false 525 false Quantitative Threshold for Recommending by USPSTF 525 False Positive Examinations per 1 death Prevented from Breast Cancer

12 False Positive Examinations Required to Prevent 1 Death Age Group Annual 2043 false 766 false Biennial 1400 false 525 false Using Threshold of 525 False Positive Examinations, we would need to reduce false by 74 percent to achieve the threshold for annual screening in women 40-49

13 Reductions in False Positives Required to Achieve USPSTF Threshold for Recommending Routine Age Group Annual Biennial percent 63 percent percent Recommended

14 Conclusions Revealed preference analyses of US Preventative Service Task force guideline makers suggest that 525 false positive examinations for every 1 additional death prevented from breast cancer to be an acceptable threshold for recommending routine screening mammography

15 Conclusions Using US Preventative Services Task forces revealed preferences, reductions of false positive proportions between percent would be required to recommend routine screening mammography beyond biennial screening in women beyond age 50.

Introduction to Cost-Effectiveness Analysis

Introduction to Cost-Effectiveness Analysis Introduction to Cost-Effectiveness Analysis Janie M. Lee, MD, MSc RSNA Clinical Trials Methodology Workshop January 13, 2016 Why is Clinical Research Important to Radiology? Radiology currently occupies

More information

Breast Cancer Screening

Breast Cancer Screening Breast Cancer Screening Claire Frost, MD R3 Talks 1 Objective 1. Understand risks and benefits of screening by reviewing current literature 2. Evaluate major society recommendations on breast cancer screening

More information

Breast Cancer Screening: Changing Philosophies in Educating Women and Teens

Breast Cancer Screening: Changing Philosophies in Educating Women and Teens Breast Cancer Screening: Changing Philosophies in Educating Women and Teens Courtney Benedict CNM MSN Disclosures Merck Nexplanon trainer Session Objectives Explain the rationale for initiation and frequency

More information

Screening for cancer in nursing home patients: Almost always a bad idea

Screening for cancer in nursing home patients: Almost always a bad idea Screening for cancer in nursing home patients: Almost always a bad idea James S. Goodwin, MD George and Cynthia Mitchell Distinguished Chair in Geriatric Medicine Director, Sealy Center on Aging August,

More information

Breast Cancer Risk Factors 8/3/2014

Breast Cancer Risk Factors 8/3/2014 Breast Cancer Screening: Changing Philosophies in Educating Women and Teens Courtney Benedict CNM MSN Session Objectives Explain the rationale for initiation and frequency of clinical breast exams to clients

More information

SCREENING FOR THYROID DYSFUNCTION U S P S T F R E C O M M E N D A T I O N S T A T E M E N T M A R I A S T U R L A 8 M A Y 2015

SCREENING FOR THYROID DYSFUNCTION U S P S T F R E C O M M E N D A T I O N S T A T E M E N T M A R I A S T U R L A 8 M A Y 2015 SCREENING FOR THYROID DYSFUNCTION U S P S T F R E C O M M E N D A T I O N S T A T E M E N T M A R I A S T U R L A 8 M A Y 2015 BACKGROUND Thyroid dysfunction represents a continuum from asymptomatic biochemical

More information

Guidelines in Breast Screening Mammography: Pros and Cons JOSLYN ALBRIGHT, MD SURGICAL ONCOLOGIST, ADVOCATE CHRIST MEDICAL CENTER OCTOBER 1, 2016

Guidelines in Breast Screening Mammography: Pros and Cons JOSLYN ALBRIGHT, MD SURGICAL ONCOLOGIST, ADVOCATE CHRIST MEDICAL CENTER OCTOBER 1, 2016 Guidelines in Breast Screening Mammography: Pros and Cons JOSLYN ALBRIGHT, MD SURGICAL ONCOLOGIST, ADVOCATE CHRIST MEDICAL CENTER OCTOBER 1, 2016 FACT Breast Cancer Screening Saves Lives Since 1990, screening

More information

Population Prospective. Big Picture

Population Prospective. Big Picture Mai Elezaby, MD? Population Prospective Big Picture Breast Cancer Most common cancer in women 2 nd leading cause of death U.S. 2016 estimates 246,660 new cases 40,450 deaths from breast cancer https://seer.cancer.gov/statfacts/html/breast.html

More information

Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care

Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process DESCRIPTION: Percentage

More information

5/24/16. Current Issues in Breast Cancer Screening. Breast cancer screening guidelines. Outline

5/24/16. Current Issues in Breast Cancer Screening. Breast cancer screening guidelines. Outline Disclosure information: An Evidence based Approach to Breast Cancer Karla Kerlikowske, MDDis Current Issues in Breast Cancer Screening Grant/Research support from: National Cancer Institute - and - Karla

More information

Untangling the Confusion: Multiple Breast Cancer Screening Guidelines and the Ones We Should Follow

Untangling the Confusion: Multiple Breast Cancer Screening Guidelines and the Ones We Should Follow Untangling the Confusion: Multiple Breast Cancer Screening Guidelines and the Ones We Should Follow Debra A. Walz, RN, MS, AOCNP, WHNP-BC, RNFA Advanced Oncology & Women s Health Nurse Practitioner Oneida

More information

Screening for Breast Cancer

Screening for Breast Cancer Understanding Task Force Recommendations Screening for Breast Cancer U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statement on Screening for Breast Cancer. se final

More information

The U.S. Preventive Services Task Force (USPSTF) CLINICAL GUIDELINE

The U.S. Preventive Services Task Force (USPSTF) CLINICAL GUIDELINE Annals of Internal Medicine CLINICAL GUIDELINE Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement Albert L. Siu, MD, MSPH, on behalf of the U.S. Preventive Services

More information

Shared Decision Making in Breast and Prostate Cancer Screening. An Update and a Patient-Centered Approach. Sharon K. Hull, MD, MPH July, 2017

Shared Decision Making in Breast and Prostate Cancer Screening. An Update and a Patient-Centered Approach. Sharon K. Hull, MD, MPH July, 2017 Shared Decision Making in Breast and Prostate Cancer Screening An Update and a Patient-Centered Approach Sharon K. Hull, MD, MPH July, 2017 Overview Epidemiology of Breast and Prostate Cancer Controversies

More information

SBI Breast Imaging Symposium 2016 Austin Texas, April 7, 2016

SBI Breast Imaging Symposium 2016 Austin Texas, April 7, 2016 Guidelines for Breast Cancer Screening: An Update SBI Breast Imaging Symposium 2016 Austin Texas, April 7, 2016 Robert A. Smith, PhD Cancer Control Department American Cancer Society Atlanta, GA I have

More information

Lung Cancer Screening: To screen or not to screen?

Lung Cancer Screening: To screen or not to screen? Lung Cancer Screening: To screen or not to screen? Dan J. Raz, M.D. Co Director, Lung Cancer Screening Program Co Director, LungCancer and Thoracic OncologyProgram Assistant Professor, Thoracic Surgery

More information

Quality ID #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care

Quality ID #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care Quality ID #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage

More information

DESCRIPTION: Percentage of women years of age who had a mammogram to screen for breast cancer

DESCRIPTION: Percentage of women years of age who had a mammogram to screen for breast cancer Quality ID #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process DESCRIPTION: Percentage

More information

Breast Cancer Screening

Breast Cancer Screening Breast Cancer Screening Eileen Rakovitch MD MSc FRCPC Sunnybrook Health Sciences Centre Medical Director, Louise Temerty Breast Cancer Centre LC Campbell Chair in Breast Cancer Research Associate Professor,

More information

Are We Ready to Predict Who is at Risk For What Kind of Breast Cancer? NOT YET NO DISCLOSURES 3/7/2015. Laura Esserman MD MBA

Are We Ready to Predict Who is at Risk For What Kind of Breast Cancer? NOT YET NO DISCLOSURES 3/7/2015. Laura Esserman MD MBA Are We Ready to Predict Who is at Risk For What Kind of Breast Cancer? NOT YET But soon.... Laura Esserman MD MBA 2 Breast Cancer Gene Expression Profiling Prognostic Tests 1. OncotypeDX Recurrence Score

More information

EBM, Study Design and Numbers. David Frankfurter, MD Professor OB/GYN The George Washington University

EBM, Study Design and Numbers. David Frankfurter, MD Professor OB/GYN The George Washington University EBM, Study Design and Numbers David Frankfurter, MD Professor OB/GYN The George Washington University 1978? 1978 Best Picture of 1978 The Deer Hunter Universal Studios The 50th Academy Awards were held

More information

Update in Breast Cancer Screening

Update in Breast Cancer Screening Disclosure information: Update in Breast Cancer Screening Karla Kerlikowske, MDDis Update in Breast Cancer Screening Grant/Research support from: National Cancer Institute and Grail - and - Karla Kerlikowske,

More information

Update in Breast Cancer Screening

Update in Breast Cancer Screening Disclosure information: Update in Breast Cancer Screening Karla Kerlikowske, MDDis Update in Breast Cancer Screening Grant/Research support from: National Cancer Institute - and - Karla Kerlikowske, MD

More information

3/21/11 Tabar et al Lancet 2003;361:

3/21/11 Tabar et al Lancet 2003;361: 1 2 3 Tabar et al Lancet 2003;361:1405-1410 4 Tabar et al Lancet 2003;361:1405-1410 Tabar Rad Clin NA 2000;38:625-652, via R. Edward Hendrick, PhD, U. Colorado 5 6 7 8 Screening 40-49 50-59 60-69 Interval

More information

Breast Screening: risks if you do and risks if you don t. Stephen W. Duffy Wolfson Institute of Preventive Medicine

Breast Screening: risks if you do and risks if you don t. Stephen W. Duffy Wolfson Institute of Preventive Medicine Breast Screening: risks if you do and risks if you don t Stephen W. Duffy Wolfson Institute of Preventive Medicine General principle There is often discussion of benefits and harms of breast screening

More information

Controversies in Breast Cancer Screening

Controversies in Breast Cancer Screening Controversies in Breast Cancer Screening Arash Naeim, MD PhD Associate Professor of Medicine Divisions of Hematology-Oncology and Geriatric Medicine David Geffen School of Medicine University of California,

More information

Controversies in Breast Cancer Screening Strategies. Breast Cancer Screening Guidelines

Controversies in Breast Cancer Screening Strategies. Breast Cancer Screening Guidelines Controversies in Breast Cancer Screening Strategies Facilitator: Mary Lou Smith, JD, MBA Research Advocacy Network Panel: Therese Bevers, MD, The University of Texas MD Anderson Cancer Center Representing:

More information

Lung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health

Lung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health Lung Cancer Screening Eric S. Papierniak, DO NF/SG VHA UF Health Overview Background Supporting evidence Guidelines Practical considerations Patient selection What to do with abnormal results Billing/coding

More information

Ann Intern Med. 2012;156(5):

Ann Intern Med. 2012;156(5): Lung Cancer Screening Update Doug Arenberg, M.D. University of Michigan Outline Screening; Some simple but necessary truths Do people benefit from screening? What are the harms (and are they outweighed

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA CMS Web Interface V2.1 Page 1 of 18 06/25/ Contents INTRODUCTION... 3 CMS WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

10.2 Summary of the Votes and Considerations for Policy

10.2 Summary of the Votes and Considerations for Policy CEPAC Voting and Policy Implications Summary Supplemental Screening for Women with Dense Breast Tissue December 13, 2013 The last CEPAC meeting addressed the comparative clinical effectiveness and value

More information

Breast Density, Screening, and Prevention

Breast Density, Screening, and Prevention Breast Density, Screening, and Prevention Amy Trentham Dietz, PhD Professor, University of Wisconsin Madison Fall 2017 Outline Why is breast density so interesting to me? Factors that influence breast

More information

Updates In Cancer Screening: Navigating a Changing Landscape

Updates In Cancer Screening: Navigating a Changing Landscape Updates In Cancer Screening: Navigating a Changing Landscape Niharika Dixit, MD I have no conflict of interest. 1 Why Should You Care Trends in Cancer Incidence by Site United States. Siegal Et al: CA

More information

Screening Mammography Policy and Politics. Kevin L. Piggott, MD, MPH August 29, 2015

Screening Mammography Policy and Politics. Kevin L. Piggott, MD, MPH August 29, 2015 Screening Mammography Policy and Politics Kevin L. Piggott, MD, MPH August 29, 2015 Objectives 1. To review the current recommendations for screening mammography by various national groups 2. To provide

More information

Breast Cancer Screening for Women at Average Risk

Breast Cancer Screening for Women at Average Risk 1/51 Special Communication October 20, 2015 Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society 1 2 3 Kevin C. Oeffinger, MD ; Elizabeth T. H. Fontham,

More information

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School Breast Cancer Screening Early detection of

More information

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School Breast Cancer Screening Early detection of

More information

Breast Cancer Update Michael B. Peyser MS MD FACS Fellow Society of Surgical Oncology Windsong Breast Care

Breast Cancer Update Michael B. Peyser MS MD FACS Fellow Society of Surgical Oncology Windsong Breast Care Breast Cancer Update 2017 Michael B. Peyser MS MD FACS Fellow Society of Surgical Oncology Windsong Breast Care Used with permission by Anna Chen MD, Windsong Radiology Group Statistics as of 2013 230,815

More information

CANCER SCREENING. Er Chaozer Department of General Medicine, Tan Tock Seng Hospital

CANCER SCREENING. Er Chaozer Department of General Medicine, Tan Tock Seng Hospital CANCER SCREENING Er Chaozer Department of General Medicine, Tan Tock Seng Hospital Introduction Screening average risk patients Benefits and harms from screening Early cancer detection early treatment

More information

Overdiagnosis in. Outline

Overdiagnosis in. Outline Overdiagnosis in Mammography Screening Jean Ching-Yuan Fann, Huei-Shian Tsau, Chen-Yang Hsu, King-Jen Chang, Amy Ming-Fang Yen, Cheng-Ping Yu, Sam Li-Sheng Chen, Wen-Hung Kuo, László Tabár, Sherry Chiu,

More information

ATHENA WISDOM INITIATIVE: RISK-BASED SCREENING FOR BREAST CANCER

ATHENA WISDOM INITIATIVE: RISK-BASED SCREENING FOR BREAST CANCER ATHENA WISDOM INITIATIVE: RISK-BASED SCREENING FOR BREAST CANCER The Screening Debate in the US? ACS vs. USPSTF When to start, when to stop, screening intervals, modality] Little guidance around operationalizing

More information

Current Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF

Current Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF Current Strategies in the Detection of Breast Cancer Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF Outline ν Screening Film Mammography ν Film ν Digital ν Screening

More information

Cancer Treatment Centers of America: Supercharge Your Knowledge: A Focus on Breast, Cervical and Prostate Screening Guidelines and Controversies

Cancer Treatment Centers of America: Supercharge Your Knowledge: A Focus on Breast, Cervical and Prostate Screening Guidelines and Controversies 8 ACOFP 55th Annual Convention & Scientific Seminars Cancer Treatment Centers of America: Supercharge Your Knowledge: A Focus on Breast, Cervical and Prostate Screening Guidelines and Controversies Anthony

More information

The Effect of the 2009 U.S. Preventive Services Task Force Breast Cancer Screening Recommendations on Mammography Rates

The Effect of the 2009 U.S. Preventive Services Task Force Breast Cancer Screening Recommendations on Mammography Rates Health Services Research Health Research and Educational Trust DOI: 10.1111/1475-6773.12445 POLICY-MANAGERIAL IMPACT ARTICLE The Effect of the 2009 U.S. Preventive Services Task Force Breast Cancer Screening

More information

Epidemiologic Methods for Evaluating Screening Programs. Rosa M. Crum, MD, MHS Johns Hopkins University

Epidemiologic Methods for Evaluating Screening Programs. Rosa M. Crum, MD, MHS Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Evidence-based Cancer Screening & Surveillance

Evidence-based Cancer Screening & Surveillance Oncology for Scientists Spring 2014 Evidence-based Cancer Screening & Surveillance Martin C. Mahoney, MD, PhD, FAAFP Departments of Medicine & Health Behavior /Oncology_Feb 2014.ppt 1 Objectives: Principles

More information

Provider Level Analyses of Screening Mammography Use in Women with Limited Life Expectancy

Provider Level Analyses of Screening Mammography Use in Women with Limited Life Expectancy Provider Level Analyses of Screening Mammography Use in Women with Limited Life Expectancy James S. Goodwin, MD George and Cynthia Mitchell Distinguished Chair in Geriatric Medicine Director, Sealy Center

More information

Leveraging Expert Knowledge to Improve Machine-Learned Decision Support Systems

Leveraging Expert Knowledge to Improve Machine-Learned Decision Support Systems Leveraging Expert Knowledge to Improve Machine-Learned Decision Support Systems Finn Kuusisto, MS 1 ; Inês Dutra, PhD 2 ; Mai Elezaby, MD 1 ; Eneida Mendonça, MD, PhD 1 ; Jude Shavlik, PhD 1 ; Elizabeth

More information

Running head: BREAST CANCER SCREENING 1

Running head: BREAST CANCER SCREENING 1 Running head: BREAST CANCER SCREENING 1 Breast Cancer Screening Carol A. Lamoureux-Lewallen Briar Cliff University BREAST CANCER SCREENING 2 Breast Cancer Screening Policy Problem The federally appointed

More information

Melissa Hartman, DO Women s Health Orlando VA Medical Center

Melissa Hartman, DO Women s Health Orlando VA Medical Center Melissa Hartman, DO Women s Health Orlando VA Medical Center Most common non-skin cancer and Second deadliest cancer in women Majority are diagnosed by abnormal screening study An approach to breast cancer

More information

Clinical Guidelines and Recommendations from the American College of Physicians: Their Role in Improving Health Care Value and Reducing Overdiagnosis

Clinical Guidelines and Recommendations from the American College of Physicians: Their Role in Improving Health Care Value and Reducing Overdiagnosis Clinical Guidelines and Recommendations from the American College of Physicians: Their Role in Improving Health Care Value and Reducing Overdiagnosis Timothy J. Wilt, Amir Qaseem, Mary Ann Forciea and

More information

Winnable Battles: Cancer in Colorado. Joni Reynolds, RN-CNS, MSN Director of Public Health Programs

Winnable Battles: Cancer in Colorado. Joni Reynolds, RN-CNS, MSN Director of Public Health Programs Winnable Battles: Cancer in Colorado Joni Reynolds, RN-CNS, MSN Director of Public Health Programs Challenging Disparities Freedom Sculpture by Zenos Frudakis CRC 5 Year Cause Specific Survival Rates 49%

More information

Annual Screening Mammography for Breast Cancer in Women 75 Years Old or Older: To Screen or Not to Screen

Annual Screening Mammography for Breast Cancer in Women 75 Years Old or Older: To Screen or Not to Screen Women s Imaging Original Research Hartman et al. Annual Screening Mammography of Women 75 Years Old or Older Women s Imaging Original Research Maya Hartman 1 Michele Drotman Elizabeth Kagan Arleo Hartman

More information

The Debate: Is screening s effect on mortality significant? Cancer incidence/death/ gender US

The Debate: Is screening s effect on mortality significant? Cancer incidence/death/ gender US WHAT IS CANCER? 1) A neoplastic Dz with a fatal natural outcome. 2) A cellular abnormality. which grows rapidly causing death. 3).. which grows slowly. 4). which stops growing. 5). which regresses. -Welch

More information

United States Preventive Services Task Force Screening Mammography Recommendations: Science Ignored

United States Preventive Services Task Force Screening Mammography Recommendations: Science Ignored Women s Imaging Perspective Hendrick and Helvie Mammography Screening Recommendations Women s Imaging Perspective FOCUS ON: R. Edward Hendrick 1 Mark A. Helvie 2 Hendrick RE, Helvie MA Keywords: breast,

More information

In its October 5, 2015, draft recommendation (draft

In its October 5, 2015, draft recommendation (draft USPSTF Colorectal Cancer Screening Guidelines: An Extended Look at Multi-Year Interval Testing Barry M. Berger, MD, FCAP; Marcus A. Parton, SB; and Bernard Levin, MD, FACP Managed Care & Healthcare Communications,

More information

Cancer Screening: Controversial Topics 10/27/17. Vijay Kudithipudi, MD Kettering Cancer Care Radiation Oncology

Cancer Screening: Controversial Topics 10/27/17. Vijay Kudithipudi, MD Kettering Cancer Care Radiation Oncology Cancer Screening: Controversial Topics 10/27/17 Vijay Kudithipudi, MD Kettering Cancer Care Radiation Oncology Meet the Radiation Oncologists E Ronald Hale, MD, MPH Matthew Knecht, MD Anthony Paravati,

More information

Breast Density. Update 2018: Implications for Clinical Practice

Breast Density. Update 2018: Implications for Clinical Practice Breast Density Update 2018: Implications for Clinical Practice Matthew A. Stein, MD Assistant professor Breast Imaging Department of Radiology and Imaging Sciences University of Utah Health Disclosures

More information

BREAST CANCER SCREENING IS A CHOICE

BREAST CANCER SCREENING IS A CHOICE BREAST CANCER SCREENING IS A CHOICE by ELAINE SCHATTNER, MD no financial disclosures (ES) American Association for Cancer Research Typical headlines focus on controversy 2 Data: Breast Cancer Incidence

More information

ISPUB.COM. Health screening: is it always worth doing? O Durojaiye BACKGROUND SCREENING PROGRAMMES SCREENING OUTCOMES VALIDITY OF SCREENING PROGRAMMES

ISPUB.COM. Health screening: is it always worth doing? O Durojaiye BACKGROUND SCREENING PROGRAMMES SCREENING OUTCOMES VALIDITY OF SCREENING PROGRAMMES ISPUB.COM The Internet Journal of Epidemiology Volume 7 Number 1 O Durojaiye Citation O Durojaiye.. The Internet Journal of Epidemiology. 2008 Volume 7 Number 1. Abstract Health screening as a preventive

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Oeffinger KC, Fontham ETH, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. doi:10.1001/jama.2015.12783.

More information

Shared Decision Making in Cancer Screening. Toby Campbell, MD Sarina Schrager, MD, MS

Shared Decision Making in Cancer Screening. Toby Campbell, MD Sarina Schrager, MD, MS Shared Decision Making in Cancer Screening Toby Campbell, MD Sarina Schrager, MD, MS Pre-activity assessment Please open the manila folder in front of you and take a few minutes to fill out the YELLOW-banded

More information

2019 CMS Web Interface

2019 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA CMS Web Interface V3.0 Page 1 of 18 xx/xx/2018 Contents INTRODUCTION... 3 CMS WEB INTERFACE SAMPLING INFORMATION... 4

More information

Screening policy across Europe has evolved with regard to its goal: Participation informed participation informed decision for or against

Screening policy across Europe has evolved with regard to its goal: Participation informed participation informed decision for or against Background Screening policy across Europe has evolved with regard to its goal: Participation informed participation informed decision for or against Informed decisions require a quantitative assessment

More information

Secondary Breast Cancer A Paradigm for Survivorship Research

Secondary Breast Cancer A Paradigm for Survivorship Research Secondary Breast Cancer A Paradigm for Survivorship Research Kevin C. Oeffinger, MD Professor of Medicine Director, Duke Center for Onco-Primary Care Director, Duke Cancer Supportive Care and Survivorship

More information

Breast Cancer Screening and Diagnosis

Breast Cancer Screening and Diagnosis Breast Cancer Screening and Diagnosis Priya Thomas, MD Assistant Professor Clinical Cancer Prevention and Breast Medical Oncology University of Texas MD Anderson Cancer Center Disclosures Dr. Thomas has

More information

BREAST CANCER SCREENING:

BREAST CANCER SCREENING: BREAST CANCER SCREENING: controversies D David Dershaw Memorial Sloan Kettering Cancer Center New York, NY Areas of general agreement about mammographic screening Screening mammography has been demonstrated

More information

Clinical Practice Guidelines Adult Preventive Health

Clinical Practice Guidelines Adult Preventive Health OERIEW Clinical Practice Guidelines The recommendations detailed in the U.S. Preventive Service Task Force s The Guide to Clinical Services 2010-2011 for Adults are considered medically necessary for the

More information

Filling Prevention Research Gaps from the USPSTF I Statements JENNIFER VILLANI, PHD, MPH NIH OFFICE OF DISEASE PREVENTION

Filling Prevention Research Gaps from the USPSTF I Statements JENNIFER VILLANI, PHD, MPH NIH OFFICE OF DISEASE PREVENTION Filling Prevention Research Gaps from the USPSTF I Statements JENNIFER VILLANI, PHD, MPH NIH OFFICE OF DISEASE PREVENTION Agenda NIH Office of Disease Prevention (ODP) US Preventive Services Task Force

More information

Page 1. Selected Controversies. Cancer Screening! Selected Controversies. Breast Cancer Screening. ! Using Best Evidence to Guide Practice!

Page 1. Selected Controversies. Cancer Screening! Selected Controversies. Breast Cancer Screening. ! Using Best Evidence to Guide Practice! Cancer Screening!! Using Best Evidence to Guide Practice! Judith M.E. Walsh, MD, MPH! Division of General Internal Medicine! Womenʼs Health Center of Excellence University of California, San Francisco!

More information

Generalised cost-effectiveness analysis for breast cancer prevention and care in Hong Kong Chinese. Wong, IOL; Tsang, JWH; Cowling, BJ; Leung, GM

Generalised cost-effectiveness analysis for breast cancer prevention and care in Hong Kong Chinese. Wong, IOL; Tsang, JWH; Cowling, BJ; Leung, GM Title Generalised cost-effectiveness analysis for breast cancer prevention and care in Hong Kong Chinese Author(s) Wong, IOL; Tsang, JWH; Cowling, BJ; Leung, GM Citation Hong Kong Medical Journal, 2015,

More information

HOW COVERAGE EXCLUSIONS IN MARKETPLACE PLANS COMPROMISE WOMEN S HEALTH AND ECONOMIC SECURITY

HOW COVERAGE EXCLUSIONS IN MARKETPLACE PLANS COMPROMISE WOMEN S HEALTH AND ECONOMIC SECURITY HOW COVERAGE EXCLUSIONS IN MARKETPLACE PLANS COMPROMISE WOMEN S HEALTH AND ECONOMIC SECURITY Dania Palanker, Georgetown University Sue Friedman, FORCE Tim Clement, Parity Track Janel George, National Women

More information

Celiac Disease: is it time for mass screening yet?

Celiac Disease: is it time for mass screening yet? Celiac Disease: is it time for mass screening yet? Edwin Liu, MD Taplin Endowed Chair for Celiac Disease Director, Colorado Center for Celiac Disease Associate Professor of Pediatrics Digestive Health

More information

An Update on Lung Cancer Screening Policy and the Role of Quitlines

An Update on Lung Cancer Screening Policy and the Role of Quitlines An Update on Lung Cancer Screening Policy and the Role of Quitlines Robert J. Volk, PhD Vance Rabius, PhD The University of Texas MD Anderson Cancer Center North American Quitline Consortium NAQC Conference

More information

TITLE: Outcomes of Screening Mammography in Elderly Women

TITLE: Outcomes of Screening Mammography in Elderly Women AD Award Number: DAMD17-00-1-0193 TITLE: Outcomes of Screening Mammography in Elderly Women PRINCIPAL INVESTIGATOR: Philip W. Chu Rebecca Smith-Bindman, M.D. CONTRACTING ORGANIZATION: University of California,

More information

Key outcomes for studies on breast cancer screening

Key outcomes for studies on breast cancer screening Key outcomes for studies on breast cancer screening Mireille Broeders, PhD 10 December 2015, Plenary ECIBC, Baveno Dept for Health Evidence, Radboudumc & Dutch Reference Centre for Screening, Nijmegen,

More information

Cancer Screenings and Early Diagnostics

Cancer Screenings and Early Diagnostics Cancer Screenings and Early Diagnostics Ankur R. Parikh, D.O. Medical Director, Center for Advanced Individual Medicine Hematologist/Medical Oncologist Atlantic Regional Osteopathic Convention April 6

More information

10/20/2015. Valerie Ballard, DNP Women s Health Nurse Practitioner

10/20/2015. Valerie Ballard, DNP Women s Health Nurse Practitioner S.Storm - Dementia Valerie Ballard, DNP Women s Health Nurse Practitioner A WELL VISIT IS PART OF A JOURNEY TO WELLNESS AND HEALTH FOR OUR PATIENTS. As a provider, take the opportunity to listen, teach

More information

European Commission Initiative on Breast Cancer (ECIBC) MEETING OF MONITORING SUBGROUP Ispra, 14 September 2016 (10:00-17:00) Minutes

European Commission Initiative on Breast Cancer (ECIBC) MEETING OF MONITORING SUBGROUP Ispra, 14 September 2016 (10:00-17:00) Minutes EUROPEAN COMMISSION DIRECTORATE GENERAL JOINT RESEARCH CENTRE Directorate F Health, Consumers and Reference Materials Unit F1 Health in Society European Commission Initiative on Breast Cancer (ECIBC) MEETING

More information

Examine breast cancer trends, statistics, and death rates, and impact of screenings. Discuss benefits and risks of screening

Examine breast cancer trends, statistics, and death rates, and impact of screenings. Discuss benefits and risks of screening Define Breast Cancer Screening Examine breast cancer trends, statistics, and death rates, and impact of screenings Discuss benefits and risks of screening Compare and contrast Screening Guidelines Optimal

More information

Colorectal Cancer Screening in Washington State

Colorectal Cancer Screening in Washington State Colorectal Cancer Screening in Washington State Susie Dade, Deputy Director, Washington Health Alliance March 25, 2016 Colorectal Cancer Roundtable Outline About the Alliance How we re doing in Washington

More information

OPTO-ACOUSTIC BREAST IMAGING

OPTO-ACOUSTIC BREAST IMAGING OPTO-ACOUSTIC BREAST IMAGING Imaging-Pathology Correlation of Opto-Acoustic Features in Benign and Malignant Breast Masses Reni Butler, M.D. F. Lee Tucker, M.D. Philip Lavin, Ph.D. Erin Neuschler, M.D.

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Hypertension QOF indicator area: Hypertension Date: July 2013

More information

Susan G. Komen Central and Northern Arizona

Susan G. Komen Central and Northern Arizona Susan G. Komen Central and Northern Arizona Frank Nagy, Mission Director WHY IS EARLY DETECTION IMPORTANT? WHY IS EARLY DETECTION IMPORTANT? Regular screening tests (along with follow-up tests and treatment

More information

North American Menopause Society (NAMS)

North American Menopause Society (NAMS) North American Menopause Society (NAMS) 2012 Hormone Therapy Position Statement Cynthia B. Evans, MD Assistant Professor-Clinical Department of Obstetrics and Gynecology The Ohio State University College

More information

Choice of screening tests

Choice of screening tests Journal of Epidemiology and Community Health, 1978, 32, 166-170 Choice of screening tests PETER R. SIMPSON AND JOCELYN CHAMBERLAIN From the Department of Community Medicine, University College Hospital

More information

Health risks of night shift work. No. 2017/17. Executive summary

Health risks of night shift work. No. 2017/17. Executive summary Health risks of night shift work No. 2017/17 Executive summary Health risks of night shift work page 2 of 5 At request of the Minister of Social Affairs and Employment, the Health Council appointed a committee

More information

CANCER SCREENING GUIDELINE CHALLENGES AND CONTROVERSIES

CANCER SCREENING GUIDELINE CHALLENGES AND CONTROVERSIES CANCER SCREENING GUIDELINE CHALLENGES AND CONTROVERSIES RICHARD C. WENDER, MD CHIEF CANCER CONTROL OFFICER AMERICAN CANCER SOCIETY @RichWender In 1996, the American Cancer Society issued a challenge goal

More information

Issue Brief: Mammography Mandates, Benchmark Plan Choices, and Essential Health Benefits

Issue Brief: Mammography Mandates, Benchmark Plan Choices, and Essential Health Benefits Issue Brief: Mammography Mandates, Benchmark Plan Choices, and Essential Health Benefits June 7, 2012 CHBRP Issue Brief: Mammography Mandates, Benchmark Plan Choices, and Essential Health Benefits June

More information

Page 1. Cancer Screening for Women I have no conflicts of interest. Overview. Breast, Colon, and Lung Cancer. Jeffrey A.

Page 1. Cancer Screening for Women I have no conflicts of interest. Overview. Breast, Colon, and Lung Cancer. Jeffrey A. Cancer Screening for Women 2017 Breast, Colon, and Lung Cancer Jeffrey A. Tice, MD Professor of Medicine Division of General Internal Medicine University of California, San Francisco I have no conflicts

More information

GENERAL COMMENTS. The Task Force Process Should be Fully Open, Balanced and Transparent

GENERAL COMMENTS. The Task Force Process Should be Fully Open, Balanced and Transparent December 9, 2013 Submitted Electronically United States Preventive Services Task Force c/o Dr. Robert Cosby Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 RE: USPSTF Draft

More information

NATIONAL GUIDELINE CLEARINGHOUSE (NGC) GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER

NATIONAL GUIDELINE CLEARINGHOUSE (NGC) GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER NATIONAL GUIDELINE CLEARINGHOUSE (NGC) GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER Guidelines 1. American Cancer Society (ACS). (1) ACS guidelines for breast cancer screening: update 2003. (2) American

More information

Current issues and controversies in breast imaging. Kate Brown, South GP CME 2015

Current issues and controversies in breast imaging. Kate Brown, South GP CME 2015 Current issues and controversies in breast imaging Kate Brown, South GP CME 2015 JUDICIOUS USE OF RESOURCES IN REFERRALS FOR BREAST IMAGING THE DILEMMA How do target referrals for breast imaging? Want

More information

Under-reporting of harm in clinical trials

Under-reporting of harm in clinical trials Under-reporting of harm in clinical trials Alberto Ocana Albacete University Hospital Albacete, Spain ESMO Copenhagen, October 10th, 2016 Disclosures I do not have any conflict of interest to declare Outline

More information

Screening Mammography: Who, what, where, when, why and how?

Screening Mammography: Who, what, where, when, why and how? Screening Mammography: Who, what, where, when, why and how? Jillian Lloyd, MD, MPH Breast Surgical Oncologist University Surgical Oncology Department of Surgery University of Tennessee Medical Center Disclosures

More information

Richard M. Hoffman, MD, MPH University of Iowa Carver College of Medicine Holden Comprehensive Cancer Center

Richard M. Hoffman, MD, MPH University of Iowa Carver College of Medicine Holden Comprehensive Cancer Center Richard M. Hoffman, MD, MPH University of Iowa Carver College of Medicine Holden Comprehensive Cancer Center Consultant, Healthwise, developing cancer screening decision support tools Consultant, Agency

More information

Cancer Screening 2009: Setting Evidence-based Priorities

Cancer Screening 2009: Setting Evidence-based Priorities Cancer Screening 2009: Setting Evidence-based Priorities Eliseo J. Pérez-Stable, MD Professor of Medicine Department of Medicine Division of General Internal Medicine University of California, San Francisco

More information

Breast Cancer Screening

Breast Cancer Screening Breast Cancer Screening October 7, 2011 Donna Fitzpatrick-Lewis, Nicole Hodgson, Donna Ciliska, Leslea Peirson, Mary Gauld, Yan Yun Liu McMaster University Hamilton, Ontario, Canada CTFPHC Leads: Marcello

More information

Learning and Earning with Gateway Professional Education CME/CEU Webinar Series. Breast Cancer Screening September 21, :00pm 1:00pm

Learning and Earning with Gateway Professional Education CME/CEU Webinar Series. Breast Cancer Screening September 21, :00pm 1:00pm Learning and Earning with Gateway Professional Education CME/CEU Webinar Series Breast Cancer Screening September 21, 2017 12:00pm 1:00pm Robert A. Smith, PhD Vice President, Cancer Screening American

More information